1. Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function 
Mireille G.F. Gerrits, Pharm.D., Hester Kramer, Ph.D., Rachid el Galta, Ph.D., Geertje van Beerendonk, Ph.D., Rob Hanssen, Ph.D., Khalid Abd-Elaziz, M.D., Christine Klipping, M.D., Ph.D., Ingrid Duijkers, M.D., Ph.D., S. Aubrey Stoch, M.D. 
Fertility and Sterility 
Volume 105, Issue 4, Pages e4 (April 2016)
DOI: /j.fertnstert
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1 Treatment schedule.
Fertility and Sterility  , e4DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

3. Supplemental Figure 1
Mean plasma concentration–time curves on day 1 (linear scale).
Fertility and Sterility  , e4DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

4. Supplemental Figure 2
Mean plasma concentration–time curves on days 1–35 (logarithmic scale).
Fertility and Sterility  , e4DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

5. Supplemental Figure 3 Structural formula of MK-8389.
Fertility and Sterility  , e4DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions